Measurement of urinary growth hormone. A noninvasive method to assess the 'growth hormone status'.
Using pharmacological tests or GH profiles, GH deficiency or active acromegaly can be diagnosed. However, it is impossible to discriminate within the continuum between 'deficiency/insufficiency' and 'sufficient secretion'. The use of GH to improve growth velocity is based on 1 injection once a day. It is thus the total amount of GH which appears to be important for its growth-promoting effect. An assay of GH in urine allows to assess such GH 'production', even over a prolonged period of time. A radiometric two-step assay applicable to untreated urine is presented. Results for assessing the 'GH status' by measuring GH in 24-hour urine, first morning-void urine or timed urine samples are shown. The correlation between 24-hour plasma profiles and the simultaneously collected 24-hour urine is significant at p less than 0.01. A correlation coefficient greater than 0.9 was found between timed urine samples (4 h) and the 120-min plasma GH values during GHRH stimulation tests. The night-to-night variation of urinary GH can be very important. It is advisable, therefore, to use the mean of several night urines. The correlation between the mean urinary GH of 5 nights to one 24-hour sample is significant at p less than 0.01. An age-dependent increase in urinary GH is found in the pubertal age group.(ABSTRACT TRUNCATED AT 250 WORDS)
Girard
J
J
University Children's Hospital, Basel, Switzerland.
Fischer-Wasels
T
T
D000293:Adolescent; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D002940:Circadian Rhythm; D005260:Female; D013006:Growth Hormone / Q000097:blood / Q000172:deficiency / Q000652:urine*; D006801:Humans; D007118:Immunoassay; D008297:Male; D010902:Pituitary Gland / Q000187:drug effects / Q000378:metabolism; D013739:Testosterone / Q000494:pharmacology; D014424:Turner Syndrome / Q000378:metabolism
D013739:Testosterone; D013006:Growth Hormone